Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2024-06-04 Regulatory Filings
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
CORIS Outperforms Manual Cleaning in Biofilm Removal 1
Regulatory Filings Classification · 95% confidence The document is a company announcement from Nanosonics Limited dated 5 June 2024. It discusses a new study about the CORIS technology outperforming manual cleaning in biofilm removal in endoscopes, referencing a publication in a scientific journal and mentioning an ongoing FDA regulatory submission. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (2429 characters) and serves as a news announcement about a technological development and regulatory update rather than a formal financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings related to financial compliance. Given the content and length, this is best classified as a Regulatory Filings (RNS) type, which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-06-04 English
Application for quotation of securities - NAN 7 pages 20.6KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and other listing rule compliance information. This type of document is specifically related to the announcement of new securities being quoted on the exchange, which falls under capital changes or share issuance. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital change event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not merely a brief announcement but a full Appendix 2A form, supporting high confidence in classification.
2024-06-04 English
Notification of cessation of securities - NAN 4 pages 14.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Nanosonics Limited. It provides specific information about securities that have ceased, including quantities and reasons for cessation. The document is a formal announcement to the ASX about changes in the company's issued capital, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial data. The document length is 3765 characters, which is relatively short and focused on a specific capital change event. This fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes such as cessation or lapse of securities. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2024-06-03 English
Nanosonics Announces FDA Regulatory Submission for CORIS 1
Regulatory Filings Classification · 95% confidence The document is a company announcement from Nanosonics regarding the submission of a regulatory application (De Novo submission) to the U.S. FDA for a new product innovation called CORIS. It discusses the regulatory submission process and future plans for commercialization. The document is short (1948 characters) and does not contain any financial data, financial results, or detailed report content. It is an announcement about a regulatory filing or submission rather than a financial report or detailed regulatory compliance document. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-04-30 English
Becoming a substantial holder 4 pages 1.8MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001 Section 671B, which pertains to notices of substantial shareholdings. It details the initial substantial holder's identity, voting power, relevant interests, registered holders, consideration paid for shares, and associates. The content includes tables of shareholdings and acquisition dates, typical of a substantial shareholding notification. There is no financial performance data, earnings information, or management discussion. The document is regulatory in nature, reporting changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification'. The document length is substantial and contains detailed data, not just an announcement or certification, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is 'MRQ' (Major Shareholding Notification).
2024-04-17 English
Change in Director's Interest Notice 4 pages 184.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in securities held by a company director, including dates, number of shares acquired, and nature of the transaction. It references ASX listing rules and the Corporations Act, indicating it is a regulatory filing related to insider trading disclosures. The content is specific to a director's personal share transactions and does not contain financial performance data or company-wide reports. Therefore, it fits the category of Director's Dealing (DIRS). The document length and detail confirm it is the actual notice, not just an announcement or certification.
2024-04-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.